(MedPage Today) — A consumer watchdog group is demanding that the HHS Office of Inspector General (OIG) look into potential conflicts of interest among members of an FDA advisory committee that recommended that six peptides be added to the list…
Source link
Watchdog Urges HHS to Investigate Conflicts Among FDA's Peptide Panelists
Show Comments (0)
Hide Comments (0)
0
0
votes
Article Rating
Subscribe
Login
0 Comments
Oldest
Newest
Most Voted
Inline Feedbacks
View all comments
